Transgenic H2B-GFP Stem Cell Line for Genotoxicity Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for assessing genotoxic potential, such as the micronucleus test, face challenges including low bioavailability of topically applied or inhaled pharmaceuticals, inter-individual variability, ethical concerns regarding animal testing, and the need for time-consuming and costly in vivo assays, which limit the effectiveness of in vitro systems in accurately detecting micronuclei formation.
Innovation Solution
A non-destructive, self-signalizing visualization method using a transgenic stem cell line from Koi carp with green fluorescent protein fused to histone 2B (H2B-GFP) allows for the identification of nuclear and chromosome anomalies, enabling non-destructive visualization of micronuclei in living cells without the need for harvesting or staining, and can be applied in both in vitro and in vivo models, including transgenic fish for aquatic sample assessment.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If in vivo mammalian erythrocyte micronucleus test is used, then genotoxic potential can be assessed, but ethical concerns arise and inter-individual variability increases
Solution Approach 1:
The patent uses a transgenic cell line that can be cultured in vitro and discarded after use, replacing the need for live animal subjects. The cell line serves as a disposable, ethically acceptable alternative that eliminates inter-individual variability while maintaining genotoxicity detection capability.
Solution Approach 2:
The invention creates a transgenic copy of mammalian cells with integrated fluorescent markers that replicate the genotoxicity response of whole organisms. This cell line copy allows assessment of genotoxic potential without using actual living animals, thus resolving ethical concerns while maintaining reliability.
2Measurement precision
If traditional chromosome aberrations test is used, then metaphase cells can be scored, but somatic inherited genetic damage cannot be assessed
Solution Approach 1:
The patent performs micronucleus formation assessment after cell division has occurred, allowing detection of somatic inherited genetic damage that would be missed in metaphase scoring. The fluorescent markers are established beforehand in the transgenic cell line, enabling subsequent detection of chromosomal abnormalities in daughter cells.
3Reliability
If in vitro micronucleus test with staining and harvesting is used, then genotoxic potential can be detected, but time-consuming and costly procedures are required
Solution Approach 1:
The transgenic cell line expresses fluorescent proteins autonomously, allowing direct visualization of nuclei and micronuclei without requiring external staining procedures. The cells self-label their own nuclear structures, eliminating time-consuming harvesting and staining steps while maintaining detection reliability.
Solution Approach 2:
The invention uses fluorescent protein markers that emit specific colors to label nuclear structures. This color-based self-labeling system replaces traditional chemical staining methods, enabling rapid detection of micronuclei through fluorescence microscopy without the time and cost of conventional staining protocols.
4Productivity
If flow cytometry automatic scoring is used, then MN frequency can be measured, but high costs and expertise requirements increase
Solution Approach 1:
The patent employs a transgenic cell line that provides built-in fluorescent markers, eliminating the need for expensive flow cytometry equipment. The cells themselves serve as the detection tool through their autonomous fluorescence, allowing microscopy-based scoring that is far less costly and requires minimal expertise compared to automated flow cytometry systems.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This method simplifies the detection of genotoxic potential by enabling visual scoring of micronuclei through fluorescence microscopy, reducing the need for high-end equipment and expert personnel, and allows for monitoring of cell survival and proliferation, providing a more efficient and ethical alternative for assessing genotoxic effects.
Implementation Method 1
green fluorescent protein fused to histone 2B (H2B-GFP) allows for the identification of nuclear and chromosome anomalies
Data Source
Figure 1
Figure 2(a)~2(b)
Figure 3(a)~3(b)
AI summary
Indicator stem cell line/transgenic (non-human) living organism for non-destructive, self-signalizing visualization of nuclear structures, which allows the identification of nuclear and chromosome anomalies - including micronuclei -as consequence of exposure to genotoxic compounds, wherein the stem cell line is a transgenic stem cell line from a (non- human) animal with nuclei labelled with a fluorescent protein fused to a chromatin-associated protein and/or the living organism is a transgenic (non-human) living organism in which a cell lineage has nuclei labelled with a fluorescent protein fused to a chromatin-associated protein.